ELF3 and cancer: High co-expression of ELF3 and HNF4A is shown in the current study to lead predominantly to gastric cancers with intestinal histology, lower grade, commonly earlier stage, and the CIN phenotype compared with cancers without up-regulated ELF3/HNF4A co-expression.